Market Cap ₹13 Cr.
Stock P/E
P/B -
Current Price ₹35
Book Value ₹ 0
Face Value 10
52W High ₹46.3
Dividend Yield 0%
52W Low ₹ 32.4
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2023 | TTM |
---|---|---|
Net Sales | 1 | |
Other Income | 0 | |
Total Income | 1 | |
Total Expenditure | 1 | |
Operating Profit | 0 | |
Interest | 0 | |
Depreciation | 0 | |
Exceptional Income / Expenses | 0 | |
Profit Before Tax | 0 | |
Provision for Tax | 0 | |
Profit After Tax | 0 | |
Adjustments | 0 | |
Profit After Adjustments | 0 | |
Adjusted Earnings Per Share | 2 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | 0% | 0% | 0% |
Operating Profit CAGR | 0% | 0% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 14% | 14% | 14% | 14% |
ROCE Average | 19% | 19% | 19% | 19% |
#(Fig in Cr.) | Mar 2023 |
---|---|
Shareholder's Funds | 1 |
Minority's Interest | 0 |
Borrowings | 0 |
Other Non-Current Liabilities | 0 |
Total Current Liabilities | 0 |
Total Liabilities | 1 |
Fixed Assets | 0 |
Other Non-Current Assets | 0 |
Total Current Assets | 1 |
Total Assets | 1 |
#(Fig in Cr.) | Mar 2023 |
---|---|
Opening Cash & Cash Equivalents | 0 |
Cash Flow from Operating Activities | -1 |
Cash Flow from Investing Activities | 0 |
Cash Flow from Financing Activities | 1 |
Net Cash Inflow / Outflow | 0 |
Closing Cash & Cash Equivalent | 0 |
# | Mar 2023 |
---|---|
Earnings Per Share (Rs) | 2.01 |
CEPS(Rs) | 2.01 |
DPS(Rs) | 0 |
Book NAV/Share(Rs) | 14.36 |
Core EBITDA Margin(%) | 14.35 |
EBIT Margin(%) | 14.35 |
Pre Tax Margin(%) | 14.33 |
PAT Margin (%) | 10.75 |
Cash Profit Margin (%) | 10.75 |
ROA(%) | 13.17 |
ROE(%) | 14.01 |
ROCE(%) | 18.71 |
Receivable days | 108.85 |
Inventory Days | 66.91 |
Payable days | 0 |
PER(x) | 0 |
Price/Book(x) | 0 |
Dividend Yield(%) | 0 |
EV/Net Sales(x) | 0.07 |
EV/Core EBITDA(x) | 0.47 |
Net Sales Growth(%) | 0 |
EBIT Growth(%) | 0 |
PAT Growth(%) | 0 |
EPS Growth(%) | 0 |
Debt/Equity(x) | 0 |
Current Ratio(x) | 16.66 |
Quick Ratio(x) | 12.92 |
Interest Cover(x) | 725 |
Total Debt/Mcap(x) | 0 |
# | Mar 2024 |
---|---|
Promoter | 76.76 |
FII | 0 |
DII | 0 |
Public | 23.24 |
Others | 0 |
Total | 100 |
# | Mar 2024 |
---|---|
Promoter | 0.18 |
FII | 0 |
DII | 0 |
Public | 0.05 |
Others | 0 |
Total | 0.23 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About